UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000034676
Receipt No. R000039534
Scientific Title Intervention and Biomarker for Mild Cognitive Impairment
Date of disclosure of the study information 2018/12/01
Last modified on 2019/05/07 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Intervention and Biomarker for Mild Cognitive Impairment
Acronym IBMCI
Scientific Title Intervention and Biomarker for Mild Cognitive Impairment
Scientific Title:Acronym IBMCI
Region
Japan

Condition
Condition Mild Cognitive Impairment
Classification by specialty
Neurology
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 In this study, an effective intervention approach for the progression of elderly with high dementia risk and exploratory study of useful biomarkers correlated with cognitive function are conducted.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes logical memory II after 6 months intervention
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Behavior,custom
Interventions/Control_1 Synapsology
6 months ( 2 times/week, 30 min/time)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
65 years-old <=
Age-upper limit
85 years-old >=
Gender Male and Female
Key inclusion criteria MMSE (Mni-mental state examination) >= 22
CDR (Clinical Dementia Rating) = 0.5
Logical memory II <= -1SD adjusted by education year
GDS (Geriatric Depression Scale) <= 6
Participant's own consent
Key exclusion criteria History of dementia
History of neurological/psychiatric disease
Severe visual or auditory impairment
Serious complications
MRI can not shoot
People can not stand quietly by resting for about 1 hour.
Target sample size 35

Research contact person
Last name of lead principal investigator
1st name Shuhei
Middle name
Last name Yamaguchi
Organization Shimane University
Division name Department of Neurology, Faculty of Medicine
Zip code 693-8501
Address 89-1, Enyacho, Izumo, Shimane
TEL 0853-20-2198
Email yamagu3n@med.shimane-u.ac.jp

Public contact
1st name of contact person
1st name Onoda
Middle name
Last name Keiichi
Organization Shimane University
Division name Department of Neurology, Faculty of Medicine
Zip code 693-8501
Address 89-1, Enyacho, Izumo, Shimane
TEL 0853-20-2198
Homepage URL
Email onodak1@med.shimane-u.ac.jp

Sponsor
Institute Shimane University
Institute
Department

Funding Source
Organization SHIMAZU
Medical Care Service
ERISA
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization The Shimane University Institutional Committee on Ethics
Address Enyacho, 89-1, Izumo, Shimane
Tel 0853-20-2515
Email kenkyu@med.shimane-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 12 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2018 Year 11 Month 10 Day
Date of IRB
2018 Year 11 Month 05 Day
Anticipated trial start date
2018 Year 11 Month 10 Day
Last follow-up date
2020 Year 06 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2018 Year 10 Month 29 Day
Last modified on
2019 Year 05 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000039534